{
    "Trade/Device Name(s)": [
        "Alere INRatio2 PT/INR Monitoring System (Professional Use)",
        "Alere INRatio2 PT/INR Home Monitoring System",
        "Alere INRatio2 PT/INR Test Strip"
    ],
    "Submitter Information": "Alere San Diego, Inc.",
    "510(k) Number": "K110212",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020679",
        "K021923",
        "K072727",
        "K092987"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "April 27, 2012",
    "Summary Letter Received Date": "April 27, 2012",
    "Submission Date": "April 12, 2012",
    "Regulation Number(s)": [
        "21CFR864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "International Normalized Ratio (INR)",
        "Prothrombin Time (PT)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "INRatio2 Monitor",
        "INRatio2 Home Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrical impedance",
        "Recombinant human thromboplastin (rhTP) reagent"
    ],
    "Methodologies": [
        "One-stage prothrombin time test"
    ],
    "Submission Type(s)": [
        "Monitoring System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Alere INRatio2 PT/INR Monitoring Systems (Professional and Home) for quantitative INR/PT measurement in capillary whole blood",
    "Indications for Use Summary": "Used for quantitative determination of INR in fresh capillary whole blood to monitor the effect of warfarin therapy on clotting time by healthcare professionals and properly trained home users; not intended for use in patients transitioning from heparin to warfarin therapy and not for screening purposes",
    "fda_folder": "Hematology"
}